Small-molecule inhibitor: gabexate mesilate

Summary Literature

Name

Common name
gabexate mesilate
Other names
FOY; FOY007

Inhibition

History
Gabexate mesilate was described in 1978 by workers at the ONO Pharmaceutical Company, Osaka.
Peptidases inhibited
A variety of 'trypsin-like' peptidases in family S1 are inhibited. Human tryptase (Ki = 95 nM: Mori et al., 2003).
Mechanism
Inhibition is reversible.
Pharmaceutical relevance
Gabexate mesilate has been used clinically as a drug, particularly for pancreatitis, coagulation disorders and allergic conditions.

Chemistry

CID at PubChem
182710
Structure
[gabexate mesilate (S01.151 inhibitor) structure ]
Chemical/biochemical name
Ethyl p-hydroxybenzoate 6-guanidinohexanoate
Formula weight
373